A California judge rejected Meta's bid to dismiss a lawsuit claiming the company designed its social media platforms to be addictive to teenagers. Despite this legal setback and a stock decline of 13% over the past year, analyst Cantor Fitzgerald maintains a Buy rating with a $750 price target, betting on Meta's artificial intelligence investments to drive future growth.
Summaries like this, in your inbox every morning.
Sign up free →What happened
On June 30th, a California judge rejected Meta Platforms Inc.'s application to dismiss a lawsuit filed by state attorneys accusing the company of designing platforms to be addictive to teenagers. The company is also reported to be selling excess computing capacity amid ongoing debate about its AI spending.
Why it matters
Meta's stock is down 13% over the past year and 2.9% year-to-date, and the addiction lawsuit adds legal risk to the company's operations. At the same time, Cantor Fitzgerald reiterated a Buy rating with a $750 share price target, signaling confidence in the company's artificial intelligence strategy despite reported concerns from its CEO about the pace of progress in agentic AI (systems that make decisions and complete tasks autonomously).
What to watch
Cantor Fitzgerald's $750 share price target and the ongoing lawsuit outcome, which could affect both the company's reputation and regulatory environment.
Meta is navigating a complex mix of legal pressure and investor confidence. The rejection of its motion to dismiss the addiction lawsuit in California adds material legal risk at a time when the company's shares have already declined significantly—down 13% over the past year. Simultaneously, reports indicate the company's CEO is unhappy with the pace of progress in agentic AI development, a key strategic priority for the firm. Despite these headwinds, analyst support remains intact: Cantor Fitzgerald's reiterated Buy rating and $750 price target suggest the market still sees value in Meta's aggressive pivot toward artificial intelligence, even as regulatory and public-health scrutiny mount. The company's plan to sell excess computing capacity reflects tension between its heavy capital spending on AI infrastructure and the absence of an established cloud computing business to monetize that capacity—a dynamic that analysts and investors are closely monitoring.
No comments yet. Be the first to share your thoughts!
Log in to join the discussion
Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.
Get Started FreeFree · takes 30 seconds · unsubscribe anytime
1 minute a day. The AI essentials.
200+ sources · Email / LINE / Slack
